A new study led by investigators from Newcastle University and the Wellcome Sanger Institute is aiming to reveal disease biomarkers in inflammatory bowel disease (IBD) and identify new and ...

"Lilly is investing in digital solutions that can help empower people with chronic conditions, such as IBD, to better manage their own health. Innovation is happening everywhere, and this ...

"Approximately 3 million Americans have reported being diagnosed with IBD, and Lilly is committed to tackling the challenge of this disease through science and innovation.